Combination of the natural product capsaicin and docetaxel synergistically kills human prostate cancer cells through the metabolic regulator AMP-activated kinase

BACKGROUND: Current chemotherapy for castration-resistant prostate cancer is established on taxane-based compounds like docetaxel. However, eventually, the development of toxic side effects and resistance limits the therapeutic benefit being the major concern in the treatment of prostate cancer. Com...

Descripción completa

Detalles Bibliográficos
Autores principales: Sánchez, Belén G., Bort, Alicia, Mateos-Gómez, Pedro A., Rodríguez-Henche, Nieves, Díaz-Laviada, Inés
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2019
Materias:
Primary Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408806/
https://www.ncbi.nlm.nih.gov/pubmed/30899201
http://dx.doi.org/10.1186/s12935-019-0769-2

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6408806/
https://www.ncbi.nlm.nih.gov/pubmed/30899201
http://dx.doi.org/10.1186/s12935-019-0769-2

Ejemplares similares